Abingworth LLP
LONDON, X0 · CIK 1397144 · 13F filing filed 2022-08-15
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityABINGWORTH LLP (GB)
- Part of THE CARLYLE GROUP INC. (US)
Other 13F filers in this group: Carlyle Group Inc. $10.0bn, AlpInvest Partners B.V. $59.9m, Carlyle Investment Management LLC files a notice
- Kindhedge funds, private equity, real estate, structured credit, futures, FCA fund manager
- Others nearbyWashington, DC, New York, NY, Amsterdam, London, Menlo Park, CA, Los Angeles, CA
- FamilyCarlyle Group Inc. · 6 related pages · largest: Carlyle Group Inc.
As an employer
In the UK
- FCA-authorised companies2
- Manages investmentsyes
- Runs fundsyes
- Retail clientsno, professional only
| Company | Staff |
|---|---|
| ABINGWORTH LLP Limited Liability PartnershipFCA: Authorised · manages AIFs | |
| CELF ADVISORS LLP Limited Liability PartnershipFCA: Authorised · manages investments, advises, deals |
Sources: Companies House (accounts filed electronically; the largest groups often file on paper, so their staff numbers can be missing), the UK gender pay gap service (employers with 250+ staff) and the FCA's Financial Services Register. Contains public sector information licensed under the Open Government Licence v3.0.
Holdings, Q2 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| VAXCYTE INC PCVX | $90.7m29.04% | Unchanged |
| SIERRA ONCOLOGY INC SRRA | $72.3m23.14% | Added +115 |
| VERA THERAPEUTICS INC VERA | $40.3m12.90% | Unchanged |
| ADICET BIO INC COM | $30.9m9.89% | Unchanged |
| HILLEVAX INC COM | $19.9m6.38% | New |
| PHATHOM PHARMACEUTICALS INC PHAT | $12.1m3.88% | Unchanged |
| JASPER THERAPEUTICS INC COM | $10.6m3.41% | Unchanged |
| VERONA PHARMA PLC VRNA | $10.2m3.26% | Added +1 |
| EFFECTOR THERAPEUTICS INC COM | $6.5m2.07% | Unchanged |
| RENEO PHARMACEUTICALS INC COM | $5.4m1.73% | Unchanged |
| SOLENO THERAPEUTICS INC SLNO | $3.2m1.01% | Unchanged |
| Spruce Bio COMMON | $3.1m0.99% | Unchanged |
| NUCANA PLC SPONSORED ADR | $2.4m0.77% | Unchanged |
| PARATEK PHARMACEUTICALS INC PRTK | $2.0m0.64% | Unchanged |
| SIENTRA INC SIEN | $1.4m0.44% | Reduced -676.2k |
| EXICURE INC XCUR | $594.0k0.19% | Reduced -6.7m |
| CYMABAY THERAPEUTICS INC CBAY | $385.0k0.12% | Unchanged |
| MOLECULAR TEMPLATES INC COM | $182.0k0.06% | Unchanged |
| OBSEVA SA COM | $141.0k0.05% | Unchanged |
| AEGLEA BIOTHERAPEUTICS INC AGLE | $121.0k0.04% | Unchanged |
| HISTOGENICS CORP COM | $16.0k0.01% | Unchanged |